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In an attempt to define the distinctive Wolf-Hirschhorn syndrome (WHS) phenotype, and to map its specific clinical
manifestations, a total of eight patients carrying a 4p16.3 microdeletion were analyzed for their clinical phenotype
and their respective genotypes. The extent of each individual deletion was established by fluorescence in situ
hybridization, with a cosmid contig spanning the genomic region from MSX1 (distal half of 4p16.1) to the sub-
telomeric locus D4S3359. The deletions were 1.9–3.5 Mb, and all were terminal. All the patients presented with
a mild phenotype, in which major malformations were usually absent. It is worth noting that head circumference
was normal for height in two patients (those with the smallest deletions [1.9 and 2.2 Mb]). The currently accepted
WHS critical region (WHSCR) was fully preserved in the patient with the 1.9-Mb deletion, in spite of a typical
WHS phenotype. The deletion in this patient spanned the chromosome region from D4S3327 (190 b4 cosmid clone
included) to the telomere. From a clinical point of view, the distinctive WHS phenotype is defined by the presence
of typical facial appearance, mental retardation, growth delay, congenital hypotonia, and seizures. These signs
represent the minimal diagnostic criteria for WHS. This basic phenotype maps distal to the currently accepted
WHSCR. Here, we propose a new critical region for WHS, and we refer to this region as “WHSCR-2.” It falls
within a 300–600-kb interval in 4p16.3, between the loci D4S3327 and D4S98-D4S168. Among the candidate
genes already described for WHS, LETM1 (leucine zipper/EF-hand-containing transmembrane) is likely to be
pathogenetically involved in seizures. On the basis of genotype-phenotype correlation analysis, dividing the WHS
phenotype into two distinct clinical entities, a “classical” and a “mild” form, is recommended for the purpose
of proper genetic counseling.
Introduction
Wolf-Hirschhorn syndrome (WHS [MIM 194190]) is a
segmental aneusomy syndrome caused by a partial 4p
deficiency. Many patients carry a deletion of several
megabases that results in severe mental and growth re-
tardation, major malformations and seizures, and a
characteristic facial appearance with wide forehead,
large and protruding eyes, hypertelorism, prominent gla-
bella, down-turned mouth, and micrognathia. In the last
few years, several patients have been reported who have
WHS and in whom a 4p16.3 microdeletion can be de-
tected only by molecular probes on apparently normal
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chromosomes. Patients in this group usually presentwith
a milder phenotype that lacks congenital malformations
(Gandelman et al. 1992; Johnson et al. 1994; Clemens
et al. 1996; Lindeman-Kusse et al. 1996; Fang et al.
1997; Partington et al. 1997; Wieczorek et al. 2000;
Zollino et al. 2000).
As a result of overlapping deletion analysis, the area
currently regarded as theWHS critical region (WHSCR)
is restricted to the 165-kb interval on 4p16.3, defined
by the loci D4S166 (cosmid 174g8 included) and
D4S3327 (cosmid 19h1 included) (Wright et al. 1997).
It was suspected that a few pleiotropic genes—or just
one gene—residing in this region may be critically re-
sponsible for the WHS phenotype, acting as transcrip-
tional regulators of other genes. Three different genes
have been independently described as candidates for
WHS. WHSC1 (Stec et al. 1998 [MIM 602952])—
identified by cosmids 19h1, 190b4, and, in part,
184d6—overlaps the distal boundary of the WHSCR.
WHSC2 (Wright et al. 1999 [MIM 606026]), which
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Table 1
Clinical and Molecular Data Related to Patients with WHS and Microdeletions
Patient
and Sex
Age at
Delivery
(wk)
Birth
Weight
(g)
Age at
Examination
(years)
Growth
Delay
Characteristic
Face MR Seizures Microcephaly
Cleft
Palate
Age at Language
Acquisition,
Walking
(mo)a
Deletion
Size
(Mb)
43, F 38 2,075 1    b   N/A 3.5c
44, M 40 2,430 11       N/A 3.5
13, M 40 2,230 12       20 2.6
46, F 40 2,650 1       N/A 2.6
14, M 40 2,600 10       28 2.5d
26, F 39 2,600 7       48 2.5
15, F 40 2,600 10       60 2.2
MG, M 40 2,500 1       N/A 1.9
NOTE.—Patients are listed according to the extent of the deletion.
a N/A p not available because of very early age at examination.
b Electroencephalographic anomalies.
c der(4)(pterrp16.3:10p15.3rpter).
d  dup(4)(p16.1p16.3).
falls entirely within the WHSCR, is identified by cos-
mid 96a2. The WHSCR flanking gene LETM1 (leucine
zipper/EF-hand–containing transmembrane [MIM
604407]), which is involved in Ca2 signaling, was re-
cently described as an excellent candidate gene for
WHS, in particular for seizures (Endele et al. 1999). It
is identified by cosmid 75b9 and PAC clone 184O23,
and it maps distally to the WHSCR. Actually, most
WHS-associated deletions, either terminal or interstitial,
are much larger than the WHSCR, usually including all
the candidate genes. Rauch et al. (2001) recently re-
ported a unique patient who had a small interstitial
deletion restricted to the WHSCR and in whom the
LETM1 gene was preserved. As pointed out by Rauch
et al. (2001), the patient presented with an atypical
WHS phenotype that included normal height, question-
able WHS facial appearance, and, more importantly, no
seizures. Another large interstitial deletion—resulting
in an atypical WHS phenotype, with no seizures—
established the distal boundary of the WHSCR (Somer
et al. 1995; Wright et al. 1997). The LETM1 gene was
also preserved in this patient.
Using the approach of genotype-phenotype correla-
tion analysis in eight informative patients, we charac-
terize the distinctive WHS clinical signs that represent
the minimal diagnostic criteria for this condition, and
we map this basic phenotype outside the currently de-
fined WHSCR.
Patients and Methods
Patients
Eight patients with WHS carrying a 4p microdeletion
(four boys and four girls), aged 1–15 years, were ana-
lyzed for their clinical phenotype and their respective
genotypes. Clinical evaluation in all patients included
heart and kidney ultrasonography and electroencepha-
lographic examination, and brain magnetic resonance
imaging (MRI) was performed in most. Individual clin-
ical signs are summarized in table 1. Patients 13, 14,
and 15 were reported elsewhere among a large series of
patients (Zollino et al. 2000). A more detailed clinical
description is in order for patient MG, and a lympho-
blastoid cell line of this patient is available.
Patient MG.—Patient MG is 12 mo old at the time of
writing and is the fifth child of healthy, nonconsanguin-
eous parents. The father was 42 and the mother 39 years
old at the time of his birth. Family history was unre-
markable. The mother underwent amniocentesis, and
results showed a normal male karyotype. Intrauterine
growth retardation was apparent during and after the
6th mo of pregnancy. MG was born at term by normal
delivery, with a birth weight of 2,500 g, a length of 48
cm, and an occipitofrontal circumference (OFC) of 32
cm. A diagnosis of congenital hypotonia was established
at an early age: sucking was poor; the infant could not
raise his head until age 4 mo; and at 12 mo he was still
unable to sit unsupported. The postnatal course was
characterized by persistent failure to thrive, with gas-
troesaphageal reflux in the first 9 mo. At the age of 9
mo, MG experienced his first episode of generalized sei-
zures, with four relapses in 1 wk. Subsequently, seizures
were controlled by anticonvulsant therapy. The boy was
also noted to have an unusual facial appearance. This,
together with failure to thrive and congenital hypotonia
and seizures, prompted a referral to one of us (M.Z.),
with the tentative diagnosis of WHS. When we first saw
him, at the age of 9 mo, length was 62 cm ( 3rd centile),K
weight was 5.5 kg ( 3rd centile), and OFC was 41 cmK
(!2nd centile) and proportionate to length. Facial ap-
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Figure 1 Frontal (a) and lateral (b) view of patient MG. Note the typical WHS facial appearance, with high forehead, frontal bossing,
large eyes, high nasal bridge, down-turned mouth, and dysmorphic ears.
pearance was undoubtedly that of WHS. The infant pre-
sented with high forehead, frontal bossing, prominent
glabella, hypertelorism, large and protruding eyes, down-
turned corners of the mouth, and abnormally shaped
and low-set ears (fig. 1). His interaction with the envi-
ronment was very good: he was interested in toys and
had good eye contact. No major malformations were
detected. Ultrasound examination of heart and kidneys
was reported to show normal results, and results of a
brain MRI were normal. Electroencephalographic ex-
amination at age 9 mo showed sequences of parieto-
occipital sharp waves and high-voltage waves with
superimposed spikes. The diagnosis of WHS was con-
firmed by many clinicians experienced in the field.
Conventional and Molecular Cytogenetics
Prometaphase chromosome analysis (600–800 bands)
was performed on peripheral blood lymphocytes by
R(RBG) banding. At least 20 metaphase spreads were
scored for each patient.
FISH analyses were performed on standard chromo-
somes, as described elsewhere (Lichter et al. 1990), with
a set of overlapping cosmids spanning the chromosome
region from the distal half of 4p16.1 to the telomere. In
each patient, FISH analyses were performed with the
subtelomeric probe for D4S3359 (Vysis) andwith probes
19h1 and 174g8, which delimit, distally and proximally,
the currently defined WHSCR (Wright et al. 1997). In-
dividual patients were analyzed further with a series of
cosmid probes that were specifically selected from
the following: MSX1, 228a7, 21f12, 247f6, 241c2,
185f6, 139h8, 212a9, 79f5, 95e6, 161c2, 33c6,
124h12 (10d12), 108f12, 141a8, 190b4, pC385.12,
pC678, IS28, and CD2. In patient MG (who has a 1.9-
Mb deletion), FISH was performed with the following
probes: 27h9, 96a2, and 184d6, in addition to the
above-mentioned 19h1, 174g8, 190b4, pC385.12, and
pC678 and the subtelomeric probe for D4S3359. Cos-
mids tested in individual patients are listed in table
2. Parents’ chromosomes were analyzed with probe
pC678 (for D4S96, which was found to be deleted in
all patients).
Results
Chromosomes
On conventional cytogenetic examination, all the pa-
tients had apparently normal chromosomes. By FISH, a
terminal 4p16.3 microdeletion was detected in each pa-
tient. The microdeletion varied in size from 1.9 Mb
(190b4 cosmid included) to 3.5 Mb (21f12 cosmid in-
cluded). Deletion sizes were established according to En-
sembl mapping and the mapping reported by Baxendale
et al. (1993). In patients 13, 14, and 15, the deletion
size was slightly different from the size reported else-
where (Zollino et al. 2000), on the basis of the updated
physical map.
It is worth noting that, on FISH results, the currently
defined WHSCR was included in the deletion interval in
seven patients, but it was fully preserved in one patient
(table 2). TheWHS-producing 4p deletion was a de novo
event in seven patients. A partial 4p duplication was
also detected in one of them (patient 14), as previously
reported (Zollino et al. 1999). In one patient, the 4p
deletion was the result of an unbalanced segregation
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Table 2
Cosmids Tested by FISH
LOCUS COSMID
DISTANCE
FROM
4pter
(Mb)a
PATIENTb
44 43 46 13 14 26 15 MG
S3359 Tel        
S90 CD2 
IS28 
S96 pC678        
S98FGFR3 pC385.12 1.8  
184d6 
S3327 190b4 1.9    
19h1 1.9        
96a2 
27h9 
174g8        
141a8 2.2 
108f12 2.2   / 
124h12 2.2 
S43 33c6 2.25       
161c2 2.35 
95e6 2.4 
79f5 2.5   /
212a9 2.5 
139h8 2.6  
185f6 2.6 / 
241c2 2.7  
S182 247f6 2.8    
S180 21f12 3.3      
S81 228a7 3.7    
MSX1 MSX1 4.7     
NOTE.— Coincident evaluations refer to overlapping cosmids (Baxendale et al. 1993).
a Distances were approximated to within 50 kb.
b /p a weak fluorescent signal on one chromosome 4 and a strong signal on the homologous
one.
of a t(4;10)(p16.3;p15.3) maternal translocation (pa-
tient 43).
Genotype-Phenotype Correlations
All the patients reported here had a relatively mild
WHS phenotype. The average age at independent walk-
ing was ∼30 mo; major malformations were absent in
most patients; and in two patients head circumference
was within normal limits, relative to height (patients 15
and MG, who carried a 2.2-Mb and a 1.9-Mb deletion,
respectively). In particular, patients 13 and 44 (aged 12
and 11 years, respectively) presented with very mild
mental delay: they were able to form complex sentences
with a rich vocabulary and could read and write. Pro-
ductive language was limited to about 20 words in pa-
tient 14, but his comprehension and his interaction with
the environment were fairly good. The more severe delay
is most likely due to the double chromosome imbalance
(dup/del 4p) detected in this patient. Patients 15 and 26
had no language and presented with a more severemotor
delay: they walked unsupported at the ages of 5 and 4
years, respectively. However, the microdeletion detected
in these patients correlated with normal head circum-
ference (for height) in patient 15 and with the absence
of major malformations in both. Although patients 43
and 46 were observed at a very young age (12 mo), lively
and sociable behavior was evident.
Cleft palate occurred in association with deletions of
3.5 and 2.6 Mb, in patients 43 and 46, respectively, who
both presented with mild psychomotor delay. Pheno-
typic variability was still evident among the present pa-
tients. Clinical manifestations shared by all the patients
included characteristic facial appearance, psychomotor
retardation, growth delay, and seizures (table 1). How-
ever, the severity of this phenotype was much less than
that observed in patients with larger deletions (Wilson
et al. 1981; Wieczorek et al. 2000; Zollino et al. 2000).
Discussion
The WHS phenotype is characterized by a particular
facial appearance, with “Greek helmet” profile, severe
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growth delay, microcephaly, profound mental retarda-
tion, congenital hypotonia, midline defects, such as cleft
palate and hypospadias, iris coloboma, congenital heart
defects, renal abnormalities, and seizures (Wilson et al.
1981). A 4p deletion of several megabases is easily de-
tectable by conventional cytogenetics in association with
this phenotype. However, in the last few years,molecular
cytogenetics allowed the detection of several 4p16.3 mi-
crodeletions in apparently normal chromosomes (Gan-
delman et al. 1992; Johnson et al. 1994; Clemens et al.
1996; Lindeman-Kusse et al. 1996; Fang et al. 1997;
Partington et al. 1997; Wieczorek et al. 2000; Zollino
et al. 2000). These small deletions usually result in a
mild phenotype lacking major malformations.
Elsewhere we have observed that genotype-phenotype
correlations in WHS mostly depend on the extent of the
deletion, with 3.5 Mb representing some sort of dis-
criminating size (Zollino et al. 2000). Physical distances
from the telomere in the patients reported elsewhere are
now slightly modified, in accordance with updated 4p
maps. Here, we report a clinical-molecular study in a
total of eight patients with microdeletions, three of
whom were described elsewhere (Zollino et al. 2000).
The deletion size varied in these patients, from 1.9 to
3.5 Mb. All of them presented with characteristic facial
appearance, growth delay, mental retardation, congen-
ital hypotonia, and seizures. With the exception of cleft
palate—which occurred in the patients with 3.5-Mb
(patient 43) and 2.6-Mb (patient 46) deletions, who
both presented with mild psychomotor delay—other
major malformations were not detected. Head circum-
ference was normal for height, in the two patients
who carried the smallest deletions (1.9 and 2.2 Mb,
respectively).
WHS can be considered a contiguous gene syndrome,
with an increasing number, as well as increasing severity,
of clinical manifestations, depending on the extent of
the deletion. Most clinical signs have been tentatively
mapped (Estabrooks et al. 1995). However, we can now
modify Estabrooks and colleagues’ phenotypic map rel-
ative to “cleft palate” and “microcephaly,” moving the
distal limit of their genomic region to a distance of 2.6
and 2.2 Mb from the telomere, respectively.
When patients carrying a large deletion are compared
with those carrying a microdeletion, the shared clinical
manifestations include characteristic facial appearance,
congenital hypotonia, mental retardation, growth delay,
and seizures. These signs define the basic WHS phe-
notype and should be regarded as minimal diagnostic
criteria for this condition. According to this view, the
critical genomic region for WHS would be the smallest
region whose haploinsufficiency gives rise to this basic
phenotype. The currently recognized WHSCR is re-
stricted to a 165-kb interval in 4p16.3, defined by the
loci D4S166 (cosmid 174g8 included) proximally and
D4S3327 (cosmid 19h1 included) distally (Wright et al.
1997). It was inferred that a few genes, or just one,
residing in this region can be responsible for the WHS
phenotype, possibly by acting as transcriptional regu-
lators of other genes. Three candidate genes have been
independently reported. WHSC1 (Stec et al. 1998),
which for two-thirds of its length overlaps with the
distal half of the WHSCR, is included in cosmids 19h1,
190b4, and, partially, 184D6. WHSC2 (Wright et al.
1999) falls entirely within the WHSCR and is included
in cosmid 96a2. The flanking gene LETM1was recently
described as a candidate gene for seizures (Endele et al.
1999). It lies just distal to the WHSCR and is identified
by cosmid 75b9 and PAC clone 184O23. The ubiqui-
tous protein encoded by LETM1 is a member of the
superfamily of EF-hand Ca2-banding proteins that re-
spond to changes in the intracellular calcium level. Since
impaired Ca2 homeostasis in nerve cells has been sug-
gested to correlate with neurodegenerative disorders
and seizures (Burgess et al. 1997), LETM1 is an excel-
lent candidate gene for neuromuscular impairment in
WHS.
The WHS-producing deletions are usually larger than
the WHSCR, including all the candidate genes. The pa-
tient with a small interstitial deletion restricted to the
WHSCR reported by Rauch et al. (2001) presentedwith
an atypical WHS phenotype, and his facial appearance,
although suggestive of WHS, was thought to reflect re-
semblance to the parents. More importantly, he had no
seizures. Therefore, a diagnosis of WHS is questionable
in this case. The patient reported by Rauch et al. (2001)
was hemizygous forWHSC2 andWHSC1, and LETM1
was fully preserved.
The distal boundary of the WHSCR was established
to occur at the level of cosmid 19h1, as a result of
the molecular analysis of a large interstitial deletion
(Somer et al. 1995; Wright et al. 1997). However, this
rearrangement also resulted in atypical WHS pheno-
type, with no seizures, and LETM1was fully preserved.
Patient MG in our series presented with a rather typical
WHS phenotype, including marked growth delay, char-
acteristic facial gestalt, psychomotor delay, and seizures
with typical EEG pattern (Sgro` et al. 1995). Yet, on
FISH analysis, the currently recognized WHSCR was
apparently fully preserved. The commercially available
FISH probe for WHS, provided by Vysis, also failed to
identify the microdeletion. By combining the manufac-
turer’s information and 4p16.3 physical maps, we con-
clude that the Vysis probe appears to span a 90-kb in-
terval of the WHSCR, including cosmids 19h1 and
96a2. A partial deletion of 19h1 in patient MG cannot
be completely ruled out on the basis of FISH analyses.
However, it can be safely concluded that this patient is
hemizygous for WHSC1, since the 5′ half of the gene
(cosmids 190b4 and 184d6) is included in the deletion
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Figure 2 Genomic organization of the WHS region in chromosome 4p16.3. With the exception of the PAC clone 184O23, all the reported
probes are cosmids, most of which were used in our analysis for FISH. A contig including all the WHS candidate genes (WHSC2, WHSC1,
and LETM1) is indicated. Note that WHSC2 is identified by cosmid 96a2; WHSC1 by cosmids 19h1, 190b4, and, in part, 184d6; and LETM1
by cosmid 75b9 and by PAC clone 184O23. Relevant 4p deletions are indicated (top).
interval. The patient of Rauch et al. was also hemizy-
gous for WHSC1, yet he did not have even the basic
WHS phenotype. Although the clinical description of
the patient initially reported by Somer et al. (1995) and
again by Wright et al. (1997) is not very detailed, he is
currently accepted as having WHS. However, we con-
sidered him atypical, like the patient of Rauch et al.
(2001), because of the absence of seizures. When we
compare patient MG with the two above-mentioned
patients with interstitial deletions (Somer et al. 1995;
Rauch et al. 2001), we must conclude that the full WHS
phenotype maps outside the WHSCR and is distal to
it.
Fang et al. (1997) described a patient with a typical
WHS phenotype, including seizures, who had an inter-
stitial deletion of ∼1.9 Mb, with distal breakpoint be-
tween loci D4S96 and D4S168 (Fang et al. 1997).
Wright et al. (1996) reported a 10-mo-old patient with
WHS who carried an interstitial deletion (also reviewed
by Fang et al. 1997) whose distal breakpoint occurred
between D4S168 and D4S98, proximal to that found
in Fang and colleagues’ patient. Relevant WHS-asso-
ciated deletions are shown in figure 2.
We conclude that the distinctive WHS phenotype
maps within a 300–600-kb interval in 4p16.3, be-
tween loci D4S3327 (patient MG) and D4S98–
D4S168 (Wright et al. 1996; also reviewed by Fang et
al. [1997]) (fig. 2). The newly proposedWHSCR, which
we designate “WHSCR-2,” is contiguous distally with
the currently defined WHSCR. At a molecular level, the
WHSC1 gene overlaps the two regions, merging its 5′
half into WHSCR-2 and merging its 3′ half into
WHSCR. However, as noted above, haploinsufficiency
of this gene does not account for the entire basic WHS
phenotype. Most likely, haploinsufficiency of WHSC1
accounts for some facial dysmorphisms, thus providing
evidence that WHS is a contiguous gene syndrome.
With respect to WHS candidate genes, WHSCR-2 in-
cludes, in addition to the 5′ moiety ofWHSC1, the entire
LETM1. Given this evidence,WHSC2 should no longer
to be considered a candidate gene for this condition.
Rauch and colleagues’ patient was hemizygous for
WHSC1 but not for LETM1. LETM1 turns out to be
the only candidate gene for seizures, as suggested else-
where (Endele et al. 1999; Rauch et al. 2001). Thus,
the hypothesis that typical WHS could be a single-gene
disorder is unlikely. We think that the full WHS phe-
notype results from the haploinsufficiency of several dif-
ferent genes, some of which, like LETM1, may directly
correlate with specific clinical signs. Additional candi-
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Table 3
WHS-Associated Microdeletions: Clinical Data
Clinical
Manifestation
No. Affected/
Total Patients %
Characteristic face 28/28 100
Growth retardation 28/28 100
Microcephaly 26/28 93
Seizures 26/27a 96
Mild congenital hypotonia 22/24 91
Mild-to-moderate mental retardation 24/27 89
Severe mental retardation 3/27 11
Congenital heart disease 0/28 0
Renal abnormalities 0/28 0
Cleft palate 2/28 7
NOTE.—Microdeletions associated with an unbalanced transloca-
tion were considered only when an estimate of the deletion size was
provided.
a A 10-mo-old patient with no seizures was excluded from this
evaluation.
date genes should be sought within the newly defined
critical region. The same consideration applies to the
diagnostic test. On the basis of overlapping analyses of
either terminal or interstitial deletions associated with
a typical WHS phenotype, D4S98 (FGFR3) appears to
be the most specific haploinsufficiency locus for the mo-
lecular diagnosis of WHS.
Finally, the evidence from the patients reported here
suggests that small deletions tend to be associated with
a milder phenotype. To confirm this conclusion, we re-
viewed a total of 28 patients with microdeletions (in-
cluding the present patients) (Gandelman et al. 1992;
Johnson et al. 1994; Clemens et al. 1996; Lindeman-
Kusse et al. 1996; Fang et al. 1997; Partington et al.
1997; Wieczorek et al. 2000) (table 3). Although some
clinical descriptions are incomplete, there is substantial
evidence that small deletions usually result in a milder
phenotype with respect to both the occurrence of major
malformations and the degree of mental retardation.
Only 3 of 28 patients with microdeletions were severely
retarded. With the exception of two patients, who pre-
sented with cleft palate and mild psychomotor delay,
major malformations were not detected. On the other
hand, phenotypic variability is largely assumed to char-
acterize the WHS, possibly in relation to other still un-
known genetic factors.
For the purpose of proper genetic diagnosis and coun-
seling, we recommend dividing WHS into a “classical”
and a “mild” form, depending on the severity of the
clinical presentation, which, in turn, is strongly corre-
lated with the size of the deletion.
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